Table IV.

Conditional quantile regression results for MPR (adherence)

	Q10	Q20	Q30	Q40	Q50	Q60	Q70
Age	0.24	0.28	0.29	0.24	0.11	0.07	0.03
Male	−0.92	0.45	1.13	0.15	−1.19	−0.87	−0.44
Northeast (ref: west)	−2.67	−2.79	−1.97	−1.68	−1.86	−0.98	−0.56
Midwest (ref: west)	−4.49	−2.60	−3.84	−2.74	−1.49	−1.15	−0.44
South (ref: west)	−8.46	−8.72	−7.87	−5.48	−3.75	−2.60	−1.28
Whether commercial (ref: Medicare Advantage)	−1.32	3.96	2.16	1.94	1.52	0.81	0.34
Baseline comorbid score	1.38	1.25	0.70	0.18	0.25	0.15	0.07
Tier 2	−8.87	−10.01	−9.07	−4.83	−3.62	−2.18	−0.49
Daily pill burden	−10.82	−12.12	−11.03	−5.26	−4.74	−3.49	−1.04
Baseline office visit count	−0.28	−0.42	−0.25	−0.10	−0.12	−0.11	−0.04
Baseline outpatient visit count	−0.17	−0.25	−0.20	−0.08	0.04	0.02	−0.01
Baseline ER visit count	−3.99	−1.69	−0.94	−0.61	−0.76	−0.55	−0.17
Baseline inpatient visit count	0.60	−0.36	−0.29	0.93	0.11	0.07	−0.14
Log of total costs	4.43	3.43	2.63	1.81	1.70	1.15	0.48
Constant	49.57	64.72	77.13	85.11	91.37	95.24	98.62

MPR, medication possession ratio; ER, emergency room.

Boldfaced estimates indicate statistical significance (p-value ≤0.05).